Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

SPECT imaging of striatal dopamine release after amphetamine challenge.

Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Charney DS, Hoffer PB, Kung HF, et al.

J Nucl Med. 1995 Jul;36(7):1182-90.

2.

Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.

Abi-Dargham A, Kegeles LS, Zea-Ponce Y, Mawlawi O, Martinez D, Mitropoulou V, O'Flynn K, Koenigsberg HW, Van Heertum R, Cooper T, Laruelle M, Siever LJ.

Biol Psychiatry. 2004 May 15;55(10):1001-6.

PMID:
15121484
3.

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans.

Kegeles LS, Zea-Ponce Y, Abi-Dargham A, Rodenhiser J, Wang T, Weiss R, Van Heertum RL, Mann JJ, Laruelle M.

Synapse. 1999 Mar 15;31(4):302-8.

PMID:
10051112
4.

Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.

Seibyl JP, Zea-Ponce Y, Brenner L, Baldwin RM, Krystal JH, Offord SJ, Mochoviak S, Charney DS, Hoffer PB, Innis RB.

J Nucl Med. 1996 Jan;37(1):11-5.

5.

Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.

Innis RB, Malison RT, al-Tikriti M, Hoffer PB, Sybirska EH, Seibyl JP, Zoghbi SS, Baldwin RM, Laruelle M, Smith EO, et al.

Synapse. 1992 Mar;10(3):177-84.

PMID:
1532675
6.

Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.

Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstätter M, Stefanova N, Diederen E, Virgolini I, Poewe W, Wenning GK.

Neuroimage. 2005 Feb 1;24(3):822-31. Epub 2004 Nov 24.

PMID:
15652317
7.
8.

Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression.

Parsey RV, Oquendo MA, Zea-Ponce Y, Rodenhiser J, Kegeles LS, Pratap M, Cooper TB, Van Heertum R, Mann JJ, Laruelle M.

Biol Psychiatry. 2001 Sep 1;50(5):313-22.

PMID:
11543733
9.

Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT.

Ichise M, Fujita M, Seibyl JP, Verhoeff NP, Baldwin RM, Zoghbi SS, Rajeevan N, Charney DS, Innis RB.

J Nucl Med. 1999 Nov;40(11):1902-12.

10.

Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects.

Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle M.

Biol Psychiatry. 2009 Jun 15;65(12):1091-3. doi: 10.1016/j.biopsych.2008.12.007. Epub 2009 Jan 23.

PMID:
19167701
11.

Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine.

Pogarell O, Koch W, Pöpperl G, Tatsch K, Jakob F, Mulert C, Grossheinrich N, Rupprecht R, Möller HJ, Hegerl U, Padberg F.

Psychiatry Res. 2007 Dec 15;156(3):251-5. Epub 2007 Nov 13.

PMID:
17993266
12.
13.

Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.

Hierholzer J, Cordes M, Venz S, Schelosky L, Harisch C, Richter W, Keske U, Hosten N, Mäurer J, Poewe W, Felix R.

J Nucl Med. 1998 Jun;39(6):954-60.

14.

Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.

Pogarell O, Koch W, Pöpperl G, Tatsch K, Jakob F, Zwanzger P, Mulert C, Rupprecht R, Möller HJ, Hegerl U, Padberg F.

J Psychiatr Res. 2006 Jun;40(4):307-14. Epub 2005 Nov 2.

PMID:
16259998
15.

Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine.

Castner SA, al-Tikriti MS, Baldwin RM, Seibyl JP, Innis RB, Goldman-Rakic PS.

Neuropsychopharmacology. 2000 Jan;22(1):4-13.

16.

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates.

Laruelle M, Iyer RN, al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW.

Synapse. 1997 Jan;25(1):1-14.

PMID:
8987142
17.

Influence of motor activity on striatal dopamine release: A study using iodobenzamide and SPECT.

Larisch R, Schommartz B, Vosberg H, Müller-Gärtner HW.

Neuroimage. 1999 Sep;10(3 Pt 1):261-8.

PMID:
10458941
18.

In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.

Dresel S, Mager T, Rossmüller B, Meisenzahl E, Hahn K, Möller HJ, Tatsch K.

Eur J Nucl Med. 1999 Aug;26(8):862-8.

PMID:
10436199
19.

Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.

Hierholzer J, Cordes M, Schelosky L, Richter W, Keske U, Venz S, Semmler W, Poewe W, Felix R.

J Nucl Med. 1994 Dec;35(12):1921-7. Erratum in: J Nucl Med 1995 Apr;36(4):568.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk